Journal article
Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with peripheral arterial disease and other high-risk conditions
- Abstract:
-
Objectives The Heart Protection Study (HPS) provides an opportunity to assess directly the effects of cholesterol-lowering therapy on major vascular events (defined as myocardial infarction, coronary death, stroke, or revascularization) in patients with peripheral arterial disease (PAD). In addition, the effects on peripheral vascular events (ie, non-coronary revascularization, aneurysm repairs, major amputations or PAD deaths) can be assessed.
Methods
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Funding
Medical Research Council
More from this funder
British Heart Foundation
More from this funder
Merck & Co.
More from this funder
Roche Vitamins Ltd.
More from this funder
Bibliographic Details
- Publisher:
- Elsevier Publisher's website
- Journal:
- Journal of Vascular Surgery Journal website
- Volume:
- 45
- Issue:
- 4
- Pages:
- 645-654
- Publication date:
- 2007-04-01
- DOI:
- ISSN:
-
0741-5214
Item Description
- Language:
- English
- Keywords:
- Subjects:
- UUID:
-
uuid:0095d98e-2a4c-419f-80bf-c127c9b1d9e3
- Local pid:
- ora:8890
- Deposit date:
- 2014-08-26
Related Items
Terms of use
- Copyright holder:
- The Society for Vascular Surgery
- Copyright date:
- 2007
- Notes:
- Copyright 2007 The Society for Vascular Surgery. Published by Elsevier B.V. All rights reserved. Re-use of this article is permitted in accordance with the Terms and Conditions set out at http://www.elsevier.com/open-access/userlicense/1.0/
- Licence:
- Other
If you are the owner of this record, you can report an update to it here: Report update to this record